by Rudolph Migliore F.X, P.C | Mar 23, 2018
Approved by the FDA to successfully reduce the risk of stroke and blood clots, Xarelto has been on the market since 2011. Since then it has endured severe ongoing litigation developing multi-million dollar verdicts for those who have suffered on behalf of the... by Rudolph Migliore F.X, P.C | Feb 23, 2018
Actemra also known as tocilizumab, is a prescription drug that has been proved by the FDA to treat a number of conditions: moderate to severe rheumatoid arthritis (RA), giant cell arthritis (GCA) in adults, and polyarticular juvenile idiopathic arthritis (PJIA) or... by Rudolph Migliore F.X, P.C | Jan 24, 2018
Tasigna, a Canadian drug that is used to treat Chronic Myeloid Leukemia, shows a connection between taking the medication and developing symptoms similar to that of atherosclerosis. Chronic Myeloid Leukemia is a type of cancer that affects the white blood cells and... by Rudolph Migliore F.X, P.C | Jan 10, 2018
Invokana, a medication designed to lower blood sugar in adults with Type Two Diabetes, has been making infamous headlines since May of 2016. Lawsuits are grounded in canagliflozin (Invokana®, Invokamet®, Invokamet® XR) causing an increased amputation risk for the leg,... by Rudolph Migliore F.X, P.C | Aug 14, 2017
Heartburn occurs when the stomach produces excess acid to breakdown ingested food and the acid refluxes into the esophagus, leaving a burning sensation in the throat. Heartburn can be treated in three different ways, with Antacids and H2 Blockers which provide...